Cargando…

Suxiao Jiuxin Pill protects cardiomyocytes against mitochondrial injury and alters gene expression during ischemic injury

Suxiao Jiuxin Pill (SX), a traditional Chinese medicine compound consisting primarily of tetramethylpyrazine and borneol, has been reported to protect against ischemic heart disease. However, the effects of SX on mitochondrial injury and gene expression in various signaling pathways are unclear. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruan, Xiaofen, Chen, Tiejun, Wang, Xiaolong, Li, Yiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639384/ https://www.ncbi.nlm.nih.gov/pubmed/29042943 http://dx.doi.org/10.3892/etm.2017.4964

Ejemplares similares

Suxiao Jiuxin Pill alleviates myocardial ischemia–reperfusion injury through the ALKBH5/GSK3β/mTOR pathway
por: Li, Yiping, et al.
Publicado: (2023)

Protective Mechanisms of Suxiao Jiuxin Pills (速效救心丸) on Myocardial Ischemia-Reperfusion Injury in vivo and in vitro
por: Tan, Ya-fang, et al.
Publicado: (2020)

Protective effect of Suxiao jiuxin pill, a traditional Chinese medicine, against acute myocardial ischemia in dogs
por: Lu, Zhiqiang, et al.
Publicado: (2015)

Suxiao Jiuxin Pill Induces Potent Relaxation and Inhibition on Contraction in Human Artery and the Mechanism
por: Bai, Xiao-Yan, et al.
Publicado: (2014)

Suxiao Jiuxin Pill attenuates acute myocardial ischemia via regulation of coronary artery tone
por: Li, Sa, et al.
Publicado: (2023)

Efficacy of Suxiao Jiuxin Pill on Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials
por: Ren, Li, et al.
Publicado: (2018)

Efficacy and safety of Suxiao Jiuxin Pill in the treatment of stable angina (Qi stagnation and blood stasis syndrome): study protocol of a randomized, double-blind, placebo-controlled, multi-center clinical trial
por: Ruan, Xiaofen, et al.
Publicado: (2021)

CaMKII, that binds with ligustilide, as a potential drug target of Suxiao jiuxin pill, a traditional Chinese medicine to dilate thoracic aorta
por: Lu, Yujie, et al.
Publicado: (2022)

Exploration of the molecular targets and mechanisms of suxiao xintong dropping pills for myocardial infarction by network pharmacology method
por: Chen, Daqiu, et al.
Publicado: (2021)

Bioactive Compounds from Germinated Brown Rice Protect Cardiomyocytes Against Simulated Ischemic/Reperfusion Injury by Ameliorating Mitochondrial Dysfunction
por: Demeekul, Kanokwan, et al.
Publicado: (2021)

Qishen Yiqi Drop Pill, a novel compound Chinese traditional medicine protects against high glucose‐induced injury in cardiomyocytes
por: Zhang, Shouyan, et al.
Publicado: (2019)

Evaluation of thyroid hormone induced pharmacological preconditioning on cardiomyocyte protection against ischemic-reperfusion injury
por: Kumar, Anil, et al.
Publicado: (2012)

Ibutilide protects against cardiomyocytes injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways
por: Wang, Yu, et al.
Publicado: (2016)

The Integrated Study on the Chemical Profiling to Explore the Constituents and Mechanism of Traditional Chinese Medicine Preparation Huatuo Jiuxin Pills Based on UPLC-Q-TOF/MS(E) and Network Pharmacology
por: Zhu, Yulong, et al.
Publicado: (2022)

Single-nucleus ribonucleic acid-sequencing and spatial transcriptomics reveal the cardioprotection of Shexiang Baoxin Pill (SBP) in mice with myocardial ischemia-reperfusion injury
por: Lin, Wenyong, et al.
Publicado: (2023)

Ischemic preconditioning protects against ischemic brain injury
por: Ma, Xiao-meng, et al.
Publicado: (2016)

Gastrodin protects H9c2 cardiomyocytes against oxidative injury by ameliorating imbalanced mitochondrial dynamics and mitochondrial dysfunction
por: Cheng, Qiao-qiao, et al.
Publicado: (2020)

Heat Shock Proteins: Protection and Potential Biomarkers for Ischemic Injury of Cardiomyocytes After Surgery
por: Santos-Junior, Valfredo de Almeida, et al.
Publicado: (2018)

Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury
por: Hara, Hironori, et al.
Publicado: (2018)

Capsaicin Protects Cardiomyocytes against Anoxia/Reoxygenation Injury via Preventing Mitochondrial Dysfunction Mediated by SIRT1
por: He, Huan, et al.
Publicado: (2017)

Protective effects of Ginkgo Biloba Dropping Pills against liver ischemia/reperfusion injury in mice
por: Wang, Zheng, et al.
Publicado: (2020)

Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitro
por: Wang, Wen-Ching, et al.
Publicado: (2012)

Fmr1 protects cardiomyocytes against lipopolysaccharide-induced myocardial injury
por: Bao, Jiasheng, et al.
Publicado: (2018)

Sanggenon C protects against cardiomyocyte hypoxia injury by increasing autophagy
por: Gu, Yang, et al.
Publicado: (2017)

Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury
por: Lin, Han-Bin, et al.
Publicado: (2014)

Heat shock proteins and protection against ischemic injury.
por: Dillmann, W H
Publicado: (1999)

Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms
por: Cai, Shunv, et al.
Publicado: (2021)

Protective effect and mechanism of procyanidin B2 against hypoxic injury of cardiomyocytes
por: Xue, Zhimin, et al.
Publicado: (2023)

Mitochondrial-Derived Vesicles Protect Cardiomyocytes Against Hypoxic Damage
por: Li, Binghu, et al.
Publicado: (2020)

Inhibition of NADPH Oxidase Mediates Protective Effect of Cardiotonic Pills against Rat Heart Ischemia/Reperfusion Injury
por: Yang, Xiao-Yuan, et al.
Publicado: (2013)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
por: Li, Yiping, et al.
Publicado: (2019)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill(®) via ameliorate of multiple mitochondrial dysfunctions
por: Chen, Jing Rui, et al.
Publicado: (2015)

Labdane diterpenes protect against anoxia/reperfusion injury in cardiomyocytes: involvement of AKT activation
por: Cuadrado, I, et al.
Publicado: (2011)

XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy
por: Shi, Xiaowen, et al.
Publicado: (2017)

Moderate hypothermia induces protection against hypoxia/reoxygenation injury by enhancing SUMOylation in cardiomyocytes
por: Chen, Jinsheng, et al.
Publicado: (2020)

Prevention and protection against cerebral ischemic injury using acupuncture
por: Peplow, Philip V., et al.
Publicado: (2016)

Progress of Research on Exosomes in the Protection Against Ischemic Brain Injury
por: Kang, Xianhui, et al.
Publicado: (2019)

Hepatic cell mobilization for protection against ischemic myocardial injury
por: Liu, Shu Q., et al.
Publicado: (2021)

The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
por: Cui, Yuan-Chen, et al.
Publicado: (2018)

Mitofusin 2 Participates in Mitophagy and Mitochondrial Fusion Against Angiotensin II-Induced Cardiomyocyte Injury
por: Xiong, Wenjun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bar0gbujjb5jondjtcjiskg1id